Rick Doblin… now his organization’s corporate spinoff, Lykos Therapeutics, may soon be acquired by Antonio Gracias, a billionaire private equity investor and close friend of the richest man in the world, Elon Musk. The planned acquisition of Lykos is an example of how tightly entwined a once left-wing psychedelic movement has become with the Trump administration and the tech right.…
In a groundbreaking study, researchers at the University of Michigan have found that a single dose of a psychedelic compound can significantly enhance cognitive flexibility, the brain’s ability to adjust to new information and changing circumstances, for several weeks. Using an innovative automated sequential learning paradigm, researchers evaluated how well mice could adapt to rule…
Certain psychiatric diseases, such as depression and schizophrenia, feature a loss of structures called dendritic spines from neurons. Dendritic spines form the receiving end of synapses, or connections between neurons. … the team tried switching the places of two atoms in LSD. This resulted in a compound that had the same 3D structure as LSD…
Newly published study findings showed that as of May 2024, 57 psilocybin stores were operating in more than a third (35.7%) of major Canadian urban centers. The majority (96.5%) were located in two provinces: Ontario and BC, whose residents collectively make up 52.5% of the nation’s population. “Our goal was to provide scientific evidence that…
What before seemed like an insurmountable problem, now seems manageable… …are doing better… both less anxious and more present, yes, they had different experiences… but both say it changed their perspective in life in general… I don’t feel like I have to push my conditions on things anymore in the relationship… I had preconceived notions…
In this case, a team of neuroscientists and clinicians documented the effects of psilocybin on a 41-year-old woman in a minimally conscious state with language-mediated responses – referred to as MCS+. One year earlier, she had suffered a traumatic brain injury. People in this state show intermittent signs of awareness, such as following commands or…
Indeed, in April [2024], the Yale School of Medicine published the results of the first randomised control study of psilocybin for pain relief. Although it enrolled just 10 CH [Cluster Headache] sufferers, half of those who received psilocybin as opposed to a placebo reported a reduction in attacks. Precisely how psilocybin interrupts the cycle of headaches is an open question. Brain scans suggest…
Portland advocates for psychedelic drug use are hoping to put an initiative on the city’s 2026 ballot that would protect people who use what they call non-toxic and non-addictive plant- or mushroom-based psychedelic drugs from arrest. Under the proposed initiative, non-toxic and non-addictive psychedelics would be designated police officers’ “lowest priority for enforcement,” according to the initiative…
Final participants are completing pre-dosing activities, including antidepressant medication washout where necessary. The trial is part of the largest randomized, controlled, double-blind psilocybin treatment clinical program ever conducted… COMP360 is being investigated as a potential… treatment for mental health conditions, administered with psychological support. Original Article (stocktitan):Compass Pathways announces completion of recruitment for the phase…
“We have New Mexicans who are suffering with various conditions that are really kind of end runs in some cases, major drug-resistant depression where the pharmaceutical world isn’t giving them any relief or they have major major side effects, they need another option,” said Sen. Steinborn. Modeled after programs in Oregon and Colorado, the bipartisan…
Recent Comments